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Summary: Some effects of liposome-incorporated amphotericin B on the permeability of the human erythrocyte
membrane to potassium and sodium ions is reported. The influence of cholesterol and amphotericin B in
causing a shift towards smaller and larger liposomes, respectively, is also described. Phosphatidylcholine
liposomes containing amphotericin B in a molar ratio of 7.4 + 0.1 (mean ± SD) antibiotic to 1000 phospho-
lipid reduced the initial rates of K+ and Na+ transport across the erythrocyte membrane to 40 + 2.6% and
0%, respectively, of their rates in the presence of comparable concentrations of free amphotericin B.
Amphotericin B incorporated into liposomes (8.2 + 0.15 μηιοί antibiotic per 1000 μηιοί total lipid) composed
of cholesterol and phosphatidylcholine (in a molar ratio of 3 : 7) reduced the initial rate of K+ transport to
19 ± 0.8% of its value measured in the presence of a comparable concentration of free antibiotic. These
results suggest that liposomes containing specified amounts of amphotericin B, especially liposomes also
containing cholesterol in addition to phosphatidylcholine, could be used as a method of controlling K+
transport across the erythrocyte and possibly other types of cellular membranes, thereby limiting antibiotic
toxicity to some mammalian tissues.
Introduction
Amphotericin B and nystatin are highly effective, but
toxic, polyene macrolide antibiotics, used in the treat-
ment of a wide range of fungal infections (1). They
achieve their fungicidal and lytic activities by com-
plexing with the sterols available in plasma mem-
branes (2 — 4), thus forming transmembrane channels,
which allow the efflux of vital cations such as potas-
sium (4, 5). They inhibit, however, the exchange of
some metabolically important anions such as phos-
phate and sulphate (6, 7). In addition, the formation
of channels leads to disruption of sterol-phospholipid
interactions in membranes (8). These combined effects
of this class of ionophoric antibiotics lead eventually
to cell lysis and death. The ability of intravenously
administered amphotericin B to form channels by
interaction with cholesterol in mammalian plasma
membranes (4), but with a lower affinity than with
fungal ergosterol (4, 28), could be the basis for its
haematopoietic, nephrotic and central nervous system
toxicities (9 — 11). Since amphotericin B is the drug
of choice for most systemic mycoses, arising as com-
plications in patients with haematological malignan-
cies (12,13) and in immunocompromised patients (14,
15), attempts have been made to reduce its toxicity
and to improve its therapeutic efficacy by incorpo-
rating it into liposomes prior to its intravenous injec-
tion (16-20).
Multilamellar liposomes (21 —23) have been used as
carriers of antimicrobial (24), antiparasitic (25) and
antineoplastic drugs (26) to improve their therapeutic
index. Liposome-incorporated amphotericin B has
been studied in a variety of experimental infections.
New et al. (16), for example, showed that liposome-
incorporated amphotericin B was less toxic and more
active against experimental Leishmaniasis than the
free drug. A lower toxicity and an equal therapeutic
efficacy were observed by Taylor et al. (18) against
experimental histoplasmosis, by Graybill et al. (17)
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against experimental cryptococcosis, and by Lopez-
Berestein (27) and Lopez-Berestein et al. (19, 20)
against experimental candidiasis.
The purpose of this study is to investigate the possible
reduction of cell damage and toxicity toward human
erythrocytes, but with obvious implications for other
cell types, by using liposome-incorporated polyene
antibiotics in conjunction with or without free ther-
apeutic steroid derivatives. In this work, liposomes
were used as carriers for specified amounts of am-
photericin B or nystatin.
Materials and Methods
Materials
Human blood, with added standard citrate-dextrose-adenine
solution, was kindly supplied by the blood bank of King Khalid
University Hospital, Riyadh. Amphotericin B was obtained
from Sigma Chemical Co., Kingston upon Thames, Surrey,
U.K. Nystatin and ouabain were purchased from Windsor
Laboratories, Slough, Berkshire, U.K. L-a-Phosphatidylcho-
line from egg yolk was provided by Calbiochem Corporation,
San Diego, U.S.A. Cholesterol was supplied by Riedel-de
Haen, Hannover, Germany. Digitoxin and digitoxigenin were
obtained from BDH Chemicals, Poole, Dorset and Koch-Light
Laboratories, Colnbrook, Bucks, U.K., respectively. Hydro-
cortisone sodium succinate in its clinical formulation was a
product of Upjohn S. A., Puurs, Belgium. All other reagents




A solution of phosphatidylcholine in methanol : chloroform
(2 :1, by vol.), was evaporated to dryness under nitrogen. The
resulting pellet was suspended in an isotonic solution of 9 g/1
NaCl by hand shaking for a few minutes to form liposomes.
Liposomes containing cholesterol were prepared by the same
method at a molar ratio of cholesterol to phospholipid of 3 : 7.
Liposomes prepared in this way were sedimented by centrifu-
gation at 700 g in a MSB Coolspin centrifuge, then suspended
in Tris-buffered saline (5 mmol/1 Tris, 4 mmol/1 KC1,146 mmol/1
NaCl, pH 7.4). The amounts of cholesterol and phospholipid
in the liposomes were estimated by determining the amounts
of these constituents in both the supernatant and the pellet.
The size distribution of the prepared liposomes was determined
using an electronic particle size analyser (Coulter Counter,
model ZM). This device simultaneously enumerates the number
of particles in each of sixteen different sizes based on average
volume.
Incorporation of antibiotics into liposomes
Prior to incorporation, antibiotics were sonicated in 9 g/1 NaCl
for 2 χ 10 s intervals on ice using a MSB Soniprep 150 at an
amplitude of 10 μηι. An aliquot of the antibiotic preparation
was taken prior to and after sonication to determine the size
distribution of antibiotic particles as described above. Sonicated
antibiotic suspensions were incubated with liposomes in Tris
buffered saline at a molar ratio of antibiotic to liposomal
phospholipids of 1 to 100 for 25 min at room temperature. To
estimate the amount of antibiotic incorporated into liposomes,
the unincorporated particulate amphotericin B or nystatin was
separated from liposomes by centrifuging the antibiotic lipid
mixtures for 10 min at 500 g. The quantity of antibiotic incor-
porated into liposomes was estimated by dissolving the pellet,
after washing it once with Tris buffered saline, in methanol :
chloroform (2:1, by vol.), then measuring the absorbance at
405 nm and 303 nm for amphotericin B and nystatin, respec-
tively, using pure antibiotics as standards. Phospholipid and
cholesterol in the supernatants were determined by the methods
of Chen et al. (29) and Leffler & McDougal (30), respectively.
The size distribution of liposome-incorporated antibiotic was
determined as described above.
Measurement of potassium and sodium transport in erythrocytes
treated with liposome-incorporated antibiotics
Erythrocytes were prepared by washing normal human blood
in Tris buffered saline and centrifuging at 1000 g for 10 min at
4 °C. After removal of the buffy coat, the erythrocytes were
washed twice again with Tris buffered saline as above. Washed
erythrocytes were pre-incubated with liposomes containing the
antibiotic, or with the free antibiotic solubilized in dimethyl
sulphoxide, using the same antibiotic concentration in both
cases. Pre-incubation was carried out for 15 min in Tris buffered
saline at a haematocrit value of 0.45 and 37 °C, in the presence
or absence of digitoxin, digitoxigenin, or hydrocortisone suc-
cinate. Controls were performed in the presence or absence of
free antibiotic, and with empty liposomes plus free cholesterol
or free phosphatidylcholine.
In order to measure sodium and potassium transport, samples
were removed from the reaction medium at various time inter-
vals and centrifuged at 2000 g for 0.5 min. Aliquots were taken
from the supernatant for haemoglobin determination using a
Boehringer Mannheim haemoglobin kit. Further aliquots of
the supernatant were taken and subsequently diluted with Tris
buffered saline for K+ determination, using a Dr. Lange M7D
flame photometer. Na+ was determined with a Pye Unicam
SP9 atomic absorption spectrophotometer, in aliquots of su-
pernatants diluted with 6% isobutanol. All concentrations of
the antibiotic, together with a control containing dimethyl
sulphoxide where necessary, were examined in duplicate in one
experiment.
Results
Effect of cholesterol on liposomal size distri-
bution
The size distribution of the prepared liposomes was
assessed using a Coulter Counter, model ZM. The
average diameter of about 95% of the phosphatidyl-
choline liposomes and those composed of both cho-
lesterol and phosphatidylcholine was less than
2.88 μηι (fig. la). However, the total number of phos-
phatidylcholine liposomes containing cholesterol was
8.3 ± 0.6% (mean ± SD) less than that of phospha-
tidylcholine liposomes lacking cholesterol. According
to the phospholipid assay, there was no increase in
the residual amount of free un-incorporated phos-
phatidylcholine molecules when liposomes were
formed from cholesterol and phosphatidylcholine in
a molar ratio of 3 : 7. The volume for each average
liposome diameter was calculated from the frequency
data, which are given in figure la. Total volume
distribution analysis (fig. Ib) showed that the volume
of cholesterol-containing liposomes was 19 + 1.3%
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Fig. 1. Effect of cholesterol on liposomal average diameter
distribution. Liposomes composed of phosphatidylcho-
line (·) or cholesterol and phosphatidylcholine (·) at a
molar ratio of 3 :7. The size distribution of the lipo-
somes was determined using an electronic particle size
analyser (Coulter Counter, model ZM) at a manometer
volume of 50 μΐ, and aperture resistance of 33.6 kQ, a
pre-set gain of 1.0, a calibration factor of 5.3, a cali-
bration diameter of 1.054 μηι and a calibration volume
of 0.6036 μηι3. Diameter calibration was performed
using latex particles, number 9316007 (Coulter electron-
ics), using an aperture diameter of 30 μηι, which
spanned a total diameter range of 0.6 —18 μηι. The data
shown correspond to 250 μΐ of liposomes containing 63
μπιοί of liposomal phosphatidyl-choline or 19 μηιοί of
liposomal cholesterol and 44 μηιοί of phosphatidylcho-
line. Liposomes were diluted 800 χ with 0.4 mmol/1
sodium pyrophosphate, pH 7.4, prior to counting. The
bottom frame (b) was drawn from calculations derived
from the data shown in the top frame (a) as described
in Materials and Methods. Each point represents the
mean of five different determinations.
less than that of liposomes lacking cholesterol, pre-
sumably partly due to the smaller total number of
liposomes of the former type. Particles larger than
2.88 μηι in diameter are expected to be mainly aggre-
gates of multilamellar liposomes.
Size distribution of amphotericin Β particles
The availability of particles of amphotericin B, and
their size distribution in Tris buffered saline, was
demonstrated using a Coulter Counter, model ZM
(fig. 2). The average diameter of more than 95% of
amphotericin B particles, prepared from sonicated or
unsonicated medium, was less than 3.45 μηι (fig. 2a).
The particles counted are most probably aggregates
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Fig. 2. The effect of sonication on size distribution of ampho-
tericin B particles. The average diameter distribution of
amphotericin B was measured under conditions similar
to those described in the legend of figure la except that
a pre-set gain of 2.0, a calibration factor of 6.35, a
calibration volume of 2.1 μηι3 and an aperture resistance
of 19.3 kQ were used. Diameter calibration was per-
formed using latex particles, number 9316008 using an
aperture diameter of 50 μηι which spanned a total range
of 0.8 to 30 μιη. The data shown correspond to 250 μΐ
of 10 μπιοΐ/ΐ stock of sonicated (·) or unsonicated (A)
amphotericin B. The amphotericin B sample taken was
diluted 400 χ with 0.4 mol/1 sodium pyrophosphate, pH
7.4, prior to counting. The bottom frame (b) was drawn
from calculations derived from the data shown in the
top frame (a) as described in Materials and Methods.
Each point represent the mean of four different deter-
minations.
quantitated by this method. The total number of
amphotericin B particles was increased by 22 ± 1.7%
upon sonication. The volume at each average dia-
meter of amphotericin B particles was calculated from
the frequency data which are given in figure 2a. Total
volume distribution analysis (fig. 2b) showed that
sonication of amphotericin B dispersions led to the
formation of a less heterogeneous population of par-
ticles (fig. 2b). Moreover, statistical analysis, in which
the data of figure 2b were summated, showed that
sonication of amphotericin B dispersions caused a
shift toward smaller particles. In spite of their higher
total count, sonicated amphotericin B particles had
about the same total volume as those of unsonicated
ones.
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Incorporation of amphotericin B into lipo-
somes and its effect on liposomal size distri-
bution
To achieve optimal conditions for incorporating am-
photericin B or nystatin into liposomes, antibiotic
dispersions were sonicated, then incubated with un-
sonicated liposomal preparations. The unpartitioned
antibiotic portion was separated from antibiotic-
loaded liposomes at low centrifugal force. The cen-
trifugation of mixtures of sonicated amphotericin B
and sonicated liposomes, or unsonicated amphoteri-
cin B and unsonicated liposomes did not efficiently
separate the un-incorporated portion of the antibiotic
from the liposome-incorporated antibiotic. The molar
ratio of incorporated antibiotic to liposomal lipid was
found to be 7.4 ± 0.1/1000 and 8.2 + 0.15/1000 in
phosphatidylcholine and cholesterol liposomes, re-
spectively. Much lower percentages of nystatin were
found to be incorporated into liposomes. The molar
ratio of antibiotic to membrane lipid was found to be
2.5 ± 0.1/1000 and 3.0 ± 0.12/1000 in phosphati-
dylcholine and phosphatidylcholine cholesterol lipo-
somes, respectively.
The average diameter distribution of liposomes con-
taining amphotericin B (fig. 3a) revealed that the
average diameter of more than 95% of liposomes,
containing or lacking cholesterol, was less than 3.6
μπι. The volume at each average liposome diameter
was calculated from the frequency data given in figure
3a. Total volume distribution analysis, in which the
data of figure 3b were summated (fig. 3b), showed
that the incorporation of amphotericin Β into choles-
terol-containing liposomes caused a shift toward
larger liposomes. Although their total count was de-
creased by 9.7% ± 1.7%, the total volume of these
liposomes was 14.6 ± 1.1% greater than that of cho-
lesterol-lacking liposomes loaded with amphotericin
Β (fig. 3b).
Permeability of the human erythrocyte mem-
brane to cations under the influence of
liposome-incorporated amphotericin Β
Incorporation of sonicated amphotericin Β into phos-
phatidylcholine liposomes at a molar antibiotic to
phospholipid ratio of 7.4 to 1000 reduced the initial
rates of K+ and Na+ transport across the erythrocyte
membrane to 40 ± 2.6% (fig. 4a) and 0% (fig. 4b),
respectively, of their rates in the presence of compa-
rable concentrations of free amphotericin B. Despite
a more efficient incorporation of amphotericin Β into
liposomes (8.2 μιηοΐ antibiotic per 1000 μπιοί lipid),
at a molar ratio of cholesterol to phosphotidylcholine
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Fig. 3. Effect of amphotericin Β on the average diameter dis-
tribution of Hposomes. The conditions for determining
the average diameter distribution were the same as those
described in the legend of figure la. The data shown
correspond to 250 μΐ of amphotericin Β incorporated
in 63 μπιοί of liposomal phosphatidylcholine (o) or 19
μπιοί of cholesterol and 44 μπιοί phosphatidylcholine
(·). Liposomes were diluted 400 χ with 0.4 mol/1 so-
dium pyrophosphate, pH 7.4, prior to counting. The
bottom frame (b) was drawn from calculations derived
from the data shown in the top frame (a) as described
in Materials and Methods. Each point represents the
mean of six different determinations.
to 19 ± 0.8% of its value with a comparable concen-
tration of free antibiotic (fig. 4a). The effects of in-
corporating higher concentrations of amphotericin B
into liposomes, on K+ and Na+ transport, were not
easy to assess. This was because the incubation of
liposomes, even with sonicated antibiotic preparations
of more than 10 μηιοΐ/ΐ concentration, led to a partial
precipitation of the un-incorporated antibiotic por-
tion with liposomes, thus preventing an accurate as-
sessment of the amount of amphotericin B incorpo-
rated into the liposomes. Potassium and sodium ion
transport were further investigated by co-incubating
antibiotic-free phosphatidylcholine cholesterol lipo-
somes and free cholesterol, to check that the efficacy
of cholesterol-containing liposome preparation, in re-
ducing K+ transport, was not due to an interaction
between amphotericin B and un-incorporated choles-
terol which might be attached to the surface of lipo-
somes during their formation. The initial rates of
transport of K+ or Na+, however, did not seem to
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 11
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Fig. 4. a. Effect of liposome-incorporated amphotericin B on the rate of K+ efflux. Washed human erythrocytes were incubated
at 37 °C with Ο μηιοΐ/ΐ (·), 8.1 μηιοΐ/ΐ (·) or 7.4 μπιοΐ/l (Δ) free amphotericin Β; amphotericin Β, incorporated in 1000
umol of liposomal phosphatidylcholine at a concentration of 7.4 μιηοΐ/ΐ, in the final suspension (D), amphotericin B,
incorporated in 1000 μπιοί of liposomal cholesterol and phosphatidylcholine at a molar ratio of 3 : 7, at a concentration
of 8.1 μηιοΐ/l in the final suspension (o). The rate of K+ effect was then monitored for 30 min.
b. Effect of liposomes containing amphotericin B on the rate of Na+ influx. Washed human erythrocytes were incubated
at 37 °C with 8.1 μιηοΐ/ΐ free amphotericin B (·), amphotericin B incorporated in 1000 μπιοί of liposomal phosphatidyl-
choline at a concentration of 7.4 μπιοΐ/l in the final suspension (o), or amphotericin B incorporated in 1000 μπιοί of
liposomal cholesterol and phosphatidylcholine at a molar ratio of 3 : 7, at a concentration of 8.1 μιηοΐ/ΐ in the final
suspension (D). The rate of Na+ effect was then monitored for 16 min. Each point represents the mean of five different
studies.
be affected by mixing free cholesterol with preformed
phosphatidylcholine cholesterol liposomes, at a molar
ratio of cholesterol to total liposomal lipids of 5 :100.
In addition, neither antibiotic-free phosphatidylcho-
line liposomes, 12.5 mmol/1 free phosphatidylcholine
or 1.5% dimethyl sulphoxide caused any haemolysis
or had any effect on the rates of K+ or Na+ transport.
On the other hand, the efficacy of phosphatidylcho-
line, or cholesterol-phosphatidylcholine (3 : 7) lipo-
somes, in minimizing the initial rate of cation ex-
change observed with free antibiotic, was reduced in
the presence of free steroidal drugs, such as digitoxi-
genin,by41 ± 3.7% and 22 ± 2.5% respectively (fig.
5a). Values in the order of 57 ± 4.1% and 16 ± 1.1%
were obtained with digitoxin under the same condi-
tions (fig. 5b). Neither digitoxigenin nor digitoxin,
however, had any effect on the initial rate of K"1"
transport in the presence of free amphotericin B alone
(figs. 5a and 5b). In addition, hydrocortisone succi-
nate had no effect on the rates of cation fluxes,
whether used with free or liposome-incorporated am-
photericin B. On the other hand, the initial rates of
K+ and Na+ transport were too low to be measured
at the relatively low molar ratios of nystatin to lipo-
somal lipids of 2.5/1000 and 3.0/1000 for phosphati-
dylcholine and cholesterol-phosphatidylcholine lipo-
somes, respectively. Furthermore, comparably low
concentrations of free nystatin failed to show any
measurable effect on K+ release.
Discussion
The degree of amphotericin B or nystatin incorpora-
tion into liposomes appeared to depend on the lipid
composition of the liposomes. The amount of am-
photericin B or nystatin incorporated into liposomes
containing cholesterol was about 11% higher than
into liposomes lacking cholesterol. This could be ex-
plained in the light of their different affinities for
sterols in biological and model membranes (2—4, 31,
32). The relatively low percentage of nystatin, as
compared with amphotericin B, incorporated into li-
posomes may be due to the combined effects of its
relatively lower partition coefficient in decane and in
the erythrocyte membrane (33) and the lower affinity
and effectiveness with which is binds (31, 32) to mem-
brane cholesterol. Moreover, using size distribution
analysis with a Coulter Counter, we showed that the
formation of liposomes from both phosphatidylcho-
line and cholesterol led to an 8.3% reduction in the
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Fig. 5. a. Effect of digitoxigenin on the rate of K+ efflux. Washed human erythrocytes were incubated at 37 °C with Ο μηιοΐ/ΐ
(D) or 150 μηιοΐ/ΐ digitoxigenin (·); amphotericin B, in 1000 μηιοί of liposomal cholesterol and phosphatidylcholine
(molar ratio 3:7) at a concentration of 8.1 μπιοΙ/1 (Δ), plus 150 μηιοΐ/ΐ digitoxigenin (A) in the final suspension;
amphotericin Β in 1000 μηιοί of liposomal phosphatidylcholine, at a concentration of 7.4 μιηοΐ/ΐ (ο), plus 150 μηιοΐ/l
digitoxigenin (·) in the final suspension; 8.1 μπιοΐ/1 free amphotericin Β (+) plus 150 μιηοΐ/ΐ digitoxigenin (x).
b. Effect of digitoxin on the rate of K+ efflux. Washed human erythrocytes were incubated at 37 °C with Ο μηιοΐ/ΐ ( + )
or 150 μηιοΐ/l (χ) digitoxin; amphotericin B in 1000 μηιοί of liposomal cholesterol and phosphatidylcholine (molar ratio
3 : 7) at a concentration of 8.1 μηιοΐ/ΐ (·), plus 150 μπιοΐ/1 digitoxin (o) in the final suspension; amphotericin B in 1000
μηιοί of liposomal phosphatidylcholine at a concentration of 7.4 μπιοΐ/1 (·), plus 150 μηιοΐ/l digitoxin (a) in the final
suspension; 7.4 μπιοΐ/1 free amphotericin B (A) plus 150 μπιοΐ/1 digitoxin (Δ). Each point represents the mean of five
different studies.
total number of liposomes formed. Nevertheless, the
total volume of liposomes containing cholesterol in
the range examined was found to be 19% lower that
that of liposomes lacking cholesterol. This indicates
a shift toward smaller liposomes and vesicles in the
former case. The shift toward smaller liposomes may
be explained by the known effect of cholesterol in
causing tighter packing of phospholipid molecules
rich in unsaturated fatty acids (34, 35), thereby allow-
ing tighter packing of individual lamellae.
The significant increase in the total number of am-
photericin B particles upon sonication can be ac-
counted for, at least in part, by sonication-induced
dispersion of large amphotericin B particles to form
smaller ones. Moreover, size distribution analysis
showed that amphotericin B incorporation shifts cho-
lesterol-containing liposomes towards a larger size
than cholesterol-lacking liposomes. This might be ex-
plained mainly by the ability of amphotericin B to
complex cholesterol, thereby rendering it unavailable
for interaction with neighbouring phospholipid mol-
ecules (8); this would cause liposomal lamellae to be
less tightly packed than those of cholesterol lacking
liposomes.
The effects of liposome-incorporated amphotericin B
on the transport profiles of cations across the mem-
brane of the human erythrocyte might be expected to
differ from those obtained with free antibiotics (6).
The transport of both cations investigated in this work
appeared to undergo significant reduction in the pres-
ence of liposome-incorporated amphotericin B, when
compared with their rates of transport with compa-
rable concentrations of free antibiotic. The more ef-
fective reduction of K+ release by cholesterol-phos-
phatidylcholine liposomes containing amphotericin B
was attributed to the relatively tight binding of am-
photericin B to the cholesterol available in liposomes.
This relatively tight binding effect impedes the ex-
change of the drug with the erythrocyte membrane,
thus reducing the drug's potential to interact with the
erythrocyte membrane and consequently to alter its
permeability properties, which may lead otherwise to
haemolysis. Thus, it appears that the type and nature
of lipids constituting the liposomes, used as drug
delivery vehicles, play an important role in controlling
the rate of drug release and the rate of cation trans-
port (and presumably anion transport) across the
human erythrocyte, and possibly other types of mam-
malian cell membrane. Therefore, the intravenous in-
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 30,1992 / No. 11
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jection of cholesterol-phosphatidylcholine liposomes
containing amphotericin B may ensure the gradual
release of the antibiotic; this would eliminate the need
for routine injections of free amphotericin B in small
doses over a period of 3—4 h (36). Moreover, the use
of cholesterol-phosphatidylcholine liposomes contain-
ing amphotericin should allow the use of a higher
single therapeutic dose, while keeping undesirable ca-
tion imbalances, and consequently the potential oc-
currence of haemolytic anaemia, under control.
On the other hand, when incorporated into either
type of liposome, the efficacy of amphotericin B in
minimizing the initial rate of cation exchange was
reduced in the presence of some free steroid drugs
such as digitoxigenin and digitoxin, used clinically in
the treatment of congestive heart failure. This effect
was attributed to the inhibitory action of these drugs
on the Na+-K+ pump (37), allowing Na+ and K+
transport to occur freely across the human erythrocyte
membrane, thus causing an ionic imbalance. Never-
theless, the initial rate of transport of K+ ions did
not seem to be affected when these two cardiotonic
steroids were mixed with comparable concentrations
of free amphotericin B. This indicates that the Na+-
K+ pump continues to be responsive to the action of
these cardiotonic steroids in the presence of the low
amounts of amphotericin B transferred from lipo-
somes to the erythrocyte membrane, but it may fail
to respond in the presence of high concentrations of
free antibiotic. This is explained by the fact that free
amphotericin B has a high partition coefficient in the
erythrocyte membrane and causes a significant per-
turbation of its normal fluidity (33), which is neces-
sary for the Na+-K+ pump to assume its usual con-
formation and activity, including its ability to bind
cardiotonic steroids.
Hydrocortisone succinate is another steroid given
with amphotericin B to reduce the febrile reactions
that may follow intravenous injection of the latter (1).
Although it contains the cholestane ring structure,
hydrocortisone succinate was found to have no effect
on the rate of K+ transport, when used in conjunction
with free or with liposome-incorporated amphotericin
B. Moreover, it did not seem to complex with am-
photericin B, as cholesterol did (2 — 4), as evidenced
by the UV absorption spectra obtained for ampho-
tericin B in the presence and absence of the drug (UV
absorption spectra not shown). This is presumably
due to the absence of a hydroxyl group at C3 in the
ring structure of hydrocortisone succinate.
It thus appears that the mechanism by which cell
damage and toxicity by amphotericin B, as applied
to human erythrocytes and possibly other types of
mammalian cells, is mediated by an increased rate of
K+ and Na+ transport. This problem can be ap-
proached by:
a) incorporating amphotericin B into liposomes;
b) deriving a method by which specific amounts of
amphotericin B can be incorporated in liposomes;
c) devising a method which allows the efficient re-
moval of un-incorporated antibiotic;
d) selecting the size distribution of amphotericin B
particles;
e) incorporating cholesterol as a constituent of the
liposomes;
f) selecting the optimal concentration of amphoteri-
cin B which has a minimal effect on membrane
fluidity and consequently on the activity of trans-
port proteins, such as the Na+-K+ pump; and
g) taking into consideration the effects of any other
drugs taken simultaneously with amphotericin B.
Incorporation of amphotericin B in liposomes may
result, however, in a reduction in the therapeutic
efficacy of the drug.
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